Physician profile
Michael Cho
NPI 1750313508
$2,116.77
in general payments reported to CMS, 2019-2025
22 companies · $321 in 2025
The $321 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $271 · 2020: $13.56 · 2021: $308 · 2022: $597 · 2023: $319 · 2024: $286 · 2025: $321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $927.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $926.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $468.98 | 2021-2024 | Truclear |
| Glaxosmithkline, LLC. | $404.48 | 2021-2025 | Nucala |
| Optinose US, INC. | $278.71 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $209.65 | 2021-2024 | Dupixent |
| Stryker Corporation | $206.14 | 2019-2021 | |
| Genzyme Corporation | $170.91 | 2023-2025 | |
| Aroa Biosurgery Incorporated | $44.55 | 2022 | |
| Smith+Nephew, INC. | $36.85 | 2025 | Tula, Halo |
| Merck Sharp & Dohme LLC | $36.55 | 2021-2025 | |
| Biocryst US Sales Co., LLC | $32.87 | 2025 | Orladeyo |
| Aerin Medical INC. | $25.20 | 2024 | |
| Novartis Pharmaceuticals Corporation | $24.42 | 2025 | |
| Alk-Abello, INC | $24.25 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $22.52 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $20.72 | 2025 | Neffy |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $20.39 | 2019 | |
| Neurent Medical Limited | $18.26 | 2022 | |
| Acclarent, INC | $17.09 | 2019 | |
| Glenmark Therapeutics INC. | $14.00 | 2019 | |
| Tactile Systems Technology INC | $14.00 | 2019 | |
| Intersect Ent, INC. | $13.56 | 2020 | |
| Depuy Synthes Sales INC. | $12.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.